Hasegawa Y, 1913. Malaria in Korea. Chosun Igakkai Zasshi 4 :53–69.
Hankey DD, Jones R, Coatney GR, Alving AS, Coker WG, Garrison PL, Donovan WL, 1953. Korean vivax malaria. I. Natural history and response to chloroquine. Am J Trop Med Hyg 2 :958–969.
Alving AS, Hankey DD, Coatney GR, Jones R, Coker WG, Garrison PL, Donovan WL, 1953. Korean vivax malaria. II. Curative treatment with pamaquine and primaquine. Am J Trop Med Hyg 2 :970–976.
Ree HI, 2000. Unstable vivax malaria in Korea. Korean J Parasitol 38 :119–138.
World Health Organization, 1981. Synopsis of the world malaria situation in 1979. Wkly Epidemiol Rec 56 :145–149.
Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW, 2003. Vivax malaria: a continuing health threat to the Republic of Korea. Am J Trop Med Hyg 69 :159–167.
Yeom JS, Ryu SH, Oh S, Lee WJ, Kim TS, Kim KH, Kim YA, Ahn SY, Cha JE, Park JW, 2005. Status of Plasmodium vivax malaria in the Republic of Korea during 2001–2003. Am J Trop Med Hyg 73 :604–608.
Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW, 2007. Plasmodium vivax malaria in the Republic of Korea during 2004–2005: changing patterns of infection. Am J Trop Med Hyg 76 :865–868.
World Health Organization Regional Office for South East Asia, 2004. Interregional Workshop on the Control of Vivax Malaria in East Asia. Available at: http://www.searo.who.int/LinkFiles/Meeting_Reports_Vivax_Mal_East_Asia_Nov_2003.pdf. Accessed February 13, 2009.
World Health Organization Regional Office for South East Asia, 2005. Control of Malaria in East Asia. Available at: http://www.searo.who.int/LinkFiles/Meeting_Reports_Control_of_Malaria_in_East_Asia.pdf. Accessed February 13, 2009.
World Health Organization Regional Office for South East Asia, 2007. Revised Malaria Control Strategy. Report of an Inter-country Workshop. Available at: http://www.searo.who.int/LinkFiles/Meeting_Reports_MAL_244.pdf. Accessed February 13, 2009.
Korea Centers for Disease Control and Prevention, 2008. Interim Evaluation of Efficacy of 2010 Malaria Eradication Project (in Korean). Seoul: Korea Centers for Disease Control and Prevention, 9–72.
Chen LH, Wilson ME, Schlagenhauf P, 2006. Prevention of malaria in long-term travelers. JAMA 296 :2234–2244.
Yeom JS, Ryu SH, Oh S, Choi DH, Song KJ, Oh YH, Lee JH, Kim YA, Ahn SY, Yang HY, Cha JE, Park JW, 2005. Evaluation of anti-malarial effects of mass chemoprophylaxis in the Republic of Korea Army. J Korean Med Sci 20 :707–712.
Lim HS, Im JS, Cho JY, Bae KS, Klein TA, Yeom JS, Kim TS, Choi JS, Jang IJ, Park JW, 2009. Pharmacokinetics of hydroxy-chloroquine and its clinical implications in the chemoprophylaxis against vivax malaria. Antimicrob Agents Chemother 53 :1468–1475.
Lee KS, Kim TH, Kim ES, Lim HS, Yeom JS, Jun G, Park JW, 2009. Chloroquine-resistant Plasmodium vivax in the Republic of Korea. Am J Trop Med Hyg 80 :215–217.
|Past two years||Past Year||Past 30 Days|
|Full Text Views||333||176||1|
Plasmodium vivax malaria, which re-emerged in the Republic of Korea (ROK) in 1993, had decreased since 2001. However, case numbers began to increase again in 2005. The number of cases rose 54.0% in 2006, but the rate of increase slowed down in 2007. Among the total of 4,206 cases of P. vivax malaria during 2006–2007, 756 cases (18.0%) were ROK military personnel, 891 cases (21.2%) were veterans, and 2,559 cases (60.8%) were civilians. The rapid increase during this period was mostly contributed by the western part of the malaria-risk areas that is under the influence of adjacent North Korea. Local transmission cases in ROK have also increased gradually and the transmission period seemingly became longer. Chemoprophylaxis in the military should be re-assessed in view of chloroquine-resistance. Continuous surveillance and monitoring are warranted to prevent further expansion of P. vivax malaria caused by climate change in ROK.